title: The role of emerging manufacturers in access to innovative vaccines of public health importance.
abstract: The role of developing country manufacturers in assuring global access to innovative vaccines was compared to the situation in 2005. These producers now supply over 60% of traditional vaccines doses globally and an increasing value (up to 15% in 2007) of innovative products. More suppliers are now strong players in global market, and an even larger group has potential to do so. These manufacturers are not a homogeneous group and most of them are now at a crossroads. Decisions made by their management and governments as well as by the international community will have a large impact on their existence and future and their ability to manufacture innovative vaccines at affordable prices.
authors.affiliation: University of Maryland School of Medicine, Geographic Medicine, 685 West Baltimore Street, Baltimore, MD 21201-1509, United States. milstien@medicine.umaryland.edu
authors.forename: Julie B
authors.initials: JB
authors.lastname: Milstien
authors.forename: Miloud
authors.initials: M
authors.lastname: Kaddar
mesh_terms: D003906:Developing Countries; D004345:Drug Industry / Q000191:economics / Q000639:trends*; D006801:Humans; D007391:International Cooperation; D017149:Private Sector; D011634:Public Health; D017150:Public Sector; D014612:Vaccines / Q000600:supply & distribution*
chemical_list: D014612:Vaccines